The FDA has granted fast track designation to UB-VV111 for the treatment of relapsed/refractory large B-cell lymphoma (LBCL) following 2 or more prior lines of therapy and relapsed/refractory chronic ...

A group of blood cancers affecting the bone marrow and blood, leukemia is a word that strikes fear in the minds of many. You may know people who have battled it, some winning and some unfortunately ...

PATIENTS with chronic lymphocytic leukemia (CLL) who consistently saw the same oncologist or hematologist experienced significantly fewer emergency room visits and hospitalizations, according to a ...

Finding seen for patients with chronic lymphocytic leukemia receiving immunoglobulin replacement therapy regularly. HealthDay News — For patients with chronic lymphocytic leukemia (CLL), regular ...

Pirtobrutinib had a nominally superior overall response rate compared to ibrutinib in certain patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The non-covalent ...

Combination therapy has potential to be an all-oral, fixed-duration regimen for previously untreated patients with CLL Application is supported by data from the Phase 3 AMPLIFY trial that showed ...

Senior Lecturer of Exercise Immunology, Faculty of Health and Medical Sciences, School of Biosciences, University of Surrey CLL starts when a type of immune cell called a B cell – normally responsible ...

Lisa McKenzie receives funding from the American Cancer Society and the University of Colorado Cancer Center. Nicole Deziel receives funding from the American Cancer Society, the National Institutes ...

Personalized exercise guidance is needed for people living with Chronic Lymphocytic Leukemia (CLL), the most common type of blood cancer, according to a new study led by the University of Surrey. The ...